HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulation/Legislation (Health)

Set Alert for Regulation {Health}

Regulation

Set Alert for Regulation {Health}

Latest From Health & Regulation

Perrigo Steers Through Transportation Obstacles, Soaring Shipping Costs From COVID-19

Perrigo largely has resolved distribution problems, but shipping freight costs still are much higher than pre-pandemic and it must divest a wound-care brand before US regulators sign off on acquisition of HRA Pharma, says CEO Murray Kessler during J.P. Morgan conference.

Coronavirus COVID-19 M & A

Califf Clears First Senate Hurdle, But FDA Decision On Abortion Pill May Complicate Final Confirmation

Republican opposition to Califf over agency’s recent move to relax its Mifeprex restrictions is ominous since, in order be confirmed as commissioner, he’ll need enough GOP votes to make up for Democratic opposition over his opioid track record and connections to pharma industry.

FDA Leadership

Government Skepticism And Over Regulation Holding Back Self-Care In France – GSCF Analysis

France's self-medication market lags behind its European rivals. Why is that? A skeptical and over-cautious government and a stifling regulatory system may provide at least part of the answer, the Global Self-Care Federation's recently published Self-Care Readiness Index suggests.  

France Health
See All

Legislation

Set Alert for Legislation {Health}

Latest From Health & Legislation

Consider Environmental Risks During OTC Reclassification, Says Sweden's Drugs Regulator

Sweden's national drugs regulator says environmental contamination risks should be reviewed as part of the overall benefit/risk assessment when reclassifying OTCs for sale outside pharmacies.

Sweden Regulation

Swiss Federal Council Wants To Liberalize Online OTC Market

Legislative changes, developments in communications and logistics technology and consumer adoption of e-commerce have prompted the Swiss Federal Council to look into liberalizing the country's OTC medicines market. 

Switzerland Health

Legislation Promotes US Medical Device Production, 'From Band-Aids To Ventilators'

Senators Tammy Baldwin and Bill Cassidy author legislation to ensure frontline workers have the supplies they need for the next potential health emergency.

 

Coronavirus COVID-19 OTC Devices
See All
UsernamePublicRestriction

Register